InvestorsObserver is giving Cortexyme Inc (CRTX) an Analyst Rating Rank of 24, meaning CRTX is ranked higher by analysts than 24% of stocks. The average price target for CRTX is $71.666 and analyst’s rate the stock as a Buy
Why are Analyst Ratings Important?
Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.
InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.
What's Happening With Cortexyme Inc Stock Today?
Cortexyme Inc (CRTX) stock is up 3.09% while the S&P 500 is down -0.56% as of 9:53 AM on Thursday, Mar 25. CRTX is higher by $1.03 from the previous closing price of $33.32 on volume of 21,575 shares. Over the past year the S&P 500 is higher by 56.22% while CRTX is down -21.07%. CRTX lost -$2.63 per share the over the last 12 months.
Click Here to get the full report on Cortexyme Inc (CRTX) Stock.
